Header Logo

Connection

GEORGE R BLUMENSCHEIN to Receptor, Platelet-Derived Growth Factor alpha

Back to Details
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Receptor, Platelet-Derived Growth Factor alpha.
GEORGE R BLUMENSCHEIN
Connection Strength
0.023
Receptor, Platelet-Derived Growth Factor alpha
  1. Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma. J Thorac Oncol. 2011 Dec; 6(12):2104-11.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.